Trial Profile
Prospective, double-blind, randomized, placebo-controlled study of raloxifene and paroxetine studying reporting of hot flashes in postmenopausal women
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Oct 2015
Price :
$35
*
At a glance
- Drugs Paroxetine (Primary) ; Raloxifene (Primary)
- Indications Hot flashes
- Focus Pharmacodynamics
- 05 Nov 2010 New trial record.